PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-11-08

Date Title Company
08-Nov-2022 Compression Stockings Market to Reach a Capital Expenditure of USD 2.4 billion by 2031 Wired Release
08-Nov-2022 Enara Bio highlights Dark Antigens™ as a novel class of targets for developing targeted immunotherapies against solid tumors Enara Bio
08-Nov-2022 Myelodysplastic Syndrome Market Growth CAGR of 9.4%, Restraints, Mergers And Forecast 2022-2031 Wired Release
08-Nov-2022 Influenza Vaccines Market Size in USD 13.58 billion to Accelerate at 8.9% CAGR Through 2031 Wired Release
08-Nov-2022 Chlorella Market Will Accelerate at a CAGR of over 6.3% through 2022-2031 Wired Release
08-Nov-2022 Nouscom’s Personalized Neoantigen Cancer Immunotherapy NOUS-PEV Demonstrates Promising Safety, Immunogenicity and Anti-tumor Activity in Solid Tumors Nouscom
08-Nov-2022 Chlorella Market Is Anticipated To Register Around 6.4% CAGR From 2022 To 2031 Wired Release
08-Nov-2022 Laboratory Information Management System market Will Accelerate at a CAGR of over 7.0% through 2022-2031 Wired Release
08-Nov-2022 Photocatalyst Market Is Anticipated To Register Around 9% CAGR From 2022-2031 Wired Release
08-Nov-2022 Aptar Pharma Announces Collaboration with TFF Pharmaceuticals to Develop Intranasal Delivery of Dry Powder Vaccines and Therapeutics Aptar Pharma
08-Nov-2022 Australia’s Telix Pharmaceuticals Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study Telix Pharmaceuticals
08-Nov-2022 Dante Genomics to present at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum Dante Genomics
08-Nov-2022 F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research F-star Therapeutics
08-Nov-2022 Kepler Vision Technologies signals further international expansion with TELEGRAFIK partnership Kepler Vision Technologies
08-Nov-2022 Enterome to present updated safety, immunogenicity and efficacy data from its Phase 1/2 trial of EO2401 in recurrent glioblastoma (ROSALIE study) at SITC 2022 Enterome
08-Nov-2022 Esya Labs Awarded $452,000 Grant from the Michael J. Fox Foundation (MJFF) to Develop Peripheral Biomarkers for Parkinson's Disease Esya Labs
08-Nov-2022 New Documentary Short Shows Why Early Intervention On Childhood Blindness Is Key To Preventing Extreme Poverty Tej Kohli & Ruit Foundation
08-Nov-2022 Block Admission Spectral MD Holdings, Ltd
08-Nov-2022 Resolution Therapeutics and CCRM sign collaboration agreement to develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies Resolution Therapeutics
08-Nov-2022 The Rhenus Group and KatalX join Pharma.Aero, the global cross-industry collaboration platform Pharma.Aero